But those same European drug companies charge more for their drugs in the US than in Europe.
There are a number of reasons (lawyers/ lawsuits in US a big one, I’m sure), but, unfortunately for us, the US market allows them the recoup their investments and make the profits needed to do further research on new drugs with our higher prices.
In my opinion, the US pricing is effectively subsidizing lower prices in the rest of the world. I wonder how many drugs these European drug companies would bring to market and at what price if the US forced the same prices as paid in Europe.
I’m not saying it’s right and, for sure, things like the Epipen price increases are pure money grabs - but it’s a far more complicated issue than many here seem to want to make it out to be.